Key facts
as of Sep 2026- It has raised $800.9M across 3 recorded rounds; the latest was Later Stage VC (Series G) ($150.0M) in Jun 2024.
- Notable investors include Fidelity Management & Research Company, OurCrowd, Baillie Gifford, Catalio Capital Management, Koch Disruptive Technologies — 29 tracked in total.
- 3 institutional filers report fund marks on Insightec across 15 filings.
- Insightec has filed 5 Form Ds with the SEC since 2018, most recently Jun 2024 ($150.0M sold to 39 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Insightec
Recorded secondary trades
No secondary trades in Insightec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
3 filers · latest Jun 20263 SEC-registered funds reported 15 fair-value marks on Insightec between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
3 roundsAbout Insightec
Developer of MRI-guided focused ultrasound devices designed to provide non-invasive treatments for a variety of oncology and gynecology indications. The company's devices are used for the treatment of uterine fibroids, tumors, and neurological disorders, such as essential tremors, neuropathic pain, and Parkinson's disease, enabling medical practitioners to treat them quickly, resulting in a higher likelihood of successful treatment.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Tirat Carmel, Israel
- Founded
- 1999
- Employees
- 494
- Website
- insightec.com/
- Ownership
- Privately Held (backing)